학술논문
A Phase 2, Open-Label Study to Evaluate the Efficacy and Safety of Mgta-145 in Combination with Plerixafor for the Mobilization of Hematopoietic Stem Cells in Patients with Sickle Cell Anemia
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:8263-8264
Subject
Language
ISSN
0006-4971